The MATTER Health Podcast

The episode provides a useful but surface-level regulatory overview - SSBCI evidence requirements, mid-year benefit reminders mandate, GAO report implications - mixed with extended vendor pitching and padded fictional case studies. A few genuine data points surface, but the ratio of insight to filler is low for a 61-minute runtime.

“plans must provide evidence um, that benefits are designed to actually improve or maintain the health of chronically ill um enrollees”

“the disenrollment rate which is for this SNP it's about 20% a huge number. Second is um ah the drop in ah star rating 10% since 2020”

The framing is almost entirely conventional - AI personalization, right benefit right member right time, engagement drives retention - with one semi-candid acknowledgment that supplemental benefits are marketing tools and the regulatory backlash that implies. No contrarian arguments, no first-principles reasoning, no counterintuitive claims.

“retention now is the new um growth”

“on the MA side, um, there's a lot of flexibility about what could potentially be, um, something that the health plan might cover. And there's a lot of innovation in that space”

Amy Schiffman is a credible physician-turned-advisor with relevant SDOH and home care experience, but her current role is consulting for startups rather than operating at scale. Duron Porat is CEO of a pre-deployment startup explicitly still closing its first pilots, making his practitioner credentials thin. This is essentially a vendor promotional webinar with affiliated speakers.

“we are early stage. We are building our um solution and currently in the process of closing a pilot with some help plans”

“since uh leaving that position I now advise um startups in go to market uh in the Medicare space”

A handful of real numbers appear - $200/member/year in supplemental benefits from a Milliman report, 20% D-SNP disenrollment rate, 10% star rating drop since 2020, employer-sponsored MAPD shrinking from roughly 20% to 10% - but most claims are vague, the regulatory citations are imprecise, and the central case study is fictional. The Milliman citation is recalled imprecisely from memory mid-conversation.

“it's just north of about 200 bucks per member. So if there's 8 million UHC Medicare Advantage folks, they're spending about $400 million a year”

“thinking in the area of 20%, and now it's dropping to 10%”

The moderator asks mostly setup questions that hand the floor to the vendor, and the format is a promotional webinar rather than an interview. The best challenge comes from audience Q&A - notably Dr. Dombrowski's question on the marketing-versus-medical-denial tension - which the host passes along but does not personally probe or push.

“there are concerns from patients and providers that the supplemental benefits recruits patients, but then more expensive medical expenses like surgery procedures and rehab are often denied. So how balance the tension between the two?”

“you're not gonna want to show in a letter that you offered 55 benefits and one got used”